Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SATRALIZUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SATRALIZUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER: Safety Overview

Metric SATRALIZUMAB SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
Total FAERS Reports 219 101
Deaths Reported 16 0
Death Rate 7.3% N/A
Hospitalizations 108 0
Average Patient Age 51.6 yrs N/A
% Female Patients 82.1% N/A
Manufacturer Genentech, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A